Boardroom tactics: Genzyme pits Whitworth against Icahn?
This article was originally published in Scrip
Executive Summary
Genzyme has reportedly appointed Ralph Whitworth, the head of one of its largest shareholders Relational Investors, to its board of directors, potentially scuppering the plans of Carl Icahn to influence the company's direction.